Latest Content

When and Why To Get Screened for Prostate Cancer

October 14th 2024, 4:22pm

By Joseph F. Renzulli MD, FACS

Video

Panelists discuss how identifying the right candidates for prostate cancer screening and understanding the role of routine screenings versus symptom-driven assessments are essential for early diagnosis and effective management.

Managing Symptoms, Controlling Disease With Radiation in Kidney Cancer

October 14th 2024, 3:00pm

By Darlene Dobkowski, MA

Video

An expert explained how radiation may be a treatment option for patients with renal cell carcinoma to manage symptoms and control the disease.

My Acute Myeloid Leukemia Diagnosis at 22 Weeks Pregnant

October 14th 2024, 1:00pm

By Harley Durham

Article

During my second trimester of pregnancy, I started to notice a weird rash, which led to other events before my diagnosis of AML.

A Strong Admiration for Oncology Nurses

October 13th 2024, 6:00pm

By David Lorber

Article

Two patients reflected on how extraordinary their oncology nurses are — even noting that they forget about their cancer when talking with their nurses.

Rybrevant Plus Chemotherapy May Improve PFS for Relapsed EGFR Lung Cancer

October 12th 2024, 6:00pm

By Darlene Dobkowski, MA

Video

The drug combined with chemotherapy demonstrated a 60% increase in progression-free survival, suggesting signs of an FDA approval.

What I Do to Help With Scanxiety

October 12th 2024, 3:00pm

By Jacqueline Greer

Article

Scans for cancer are never easy, especially when waiting for the results, but I’ve found ways to help me through these intimidating moments.

Removing More Lymph Nodes May Not Improve Survival in Muscle-Invasive Bladder Cancer

October 11th 2024, 9:00pm

By Darlene Dobkowski, MA

Article

Removing more lymph nodes during surgery may also increase the risk for death after surgery in muscle-invasive bladder cancer.

PCV Chemo Plus Radiation Shows Improved Survival in Brain Cancer, Consider Safety

October 11th 2024, 7:00pm

By Ashley Chan

Article

In some with grade 3 brain cancer, adding PCV chemotherapy regimen to radiation showed better survival outcomes than another type of chemotherapy, but safety should be considered.

Staying on the Course After Testicular Cancer

October 11th 2024, 5:00pm

By Brian Sluga

Article

After my surgery for testicular cancer, my good friend Joe helped me through my goal of training and running a marathon.

‘The Office’ Actress Opens Up About Breast Cancer, Martha Davis Cancels Concerts After Radiation and More

October 11th 2024, 3:00pm

By Alex Biese

Article

From Jenna Fischer announcing her breast cancer diagnosis to Martha Davis and the Motels canceling concerts after her radiation therapy, here’s what’s happening in the cancer space this week.

A Promise to My Firstborn While Caregiving for My Youngest

October 11th 2024, 1:00pm

By Mark Younce

Article

While being a caregiver to my youngest daughter with brain cancer, I felt emotional turmoil while being away from my firstborn daughter.

FDA Approves Itovebi Combo for Some With Advanced Breast Cancer

October 10th 2024, 8:13pm

By Alex Biese

Article

The Food and Drug Administration (FDA) has approved Itovebi (inavolisib) with Ibrance (palbociclib) and Faslodex (fulvestrant) for certain patients with advanced or metastatic breast cancer.

SBRT, CRT Radiation Therapies May Not Have Many Differences for NSCLC

October 10th 2024, 7:00pm

By Ashley Chan

Article

Two radiation therapy techniques, SBRT and hypofractionated CRT, may not have many differences for patients with stage 1 NSCLC, but limitations matter.

I Still Reflect on My Lung Cancer Treatment Decisions

October 10th 2024, 5:00pm

By Sue McCarthy

Article

When I was diagnosed with lung cancer, I didn’t want to receive chemotherapy, especially when I was a good candidate for immunotherapy.

Dato-DXd May Improve Progression-Free Survival in Breast Cancer Subset

October 10th 2024, 3:00pm

By Spencer Feldman

Article

For a subset of patients with inoperable or metastatic HR-positive/HER2-negative breast cancer, treatment with datopotamab deruxtecan improved progression-free survival.